Correction: An Acquired HER2 ^T798I Gatekeeper Mutation Induces Resistance to Neratinib in a Patient with HER2 Mutant-Driven Breast Cancer. Academic Article

Overview

authors

Hanker, Ariella B

Brewer, Monica Red

Sheehan, Jonathan H

Sliwoski, Gregory R

Lanman, Richard

Berger, Michael
Hyman, David M
Solit, David B
He, Jie
Miller, Vincent
Cutler, Richard E
Lalani, Alshad S
Cross, Darren
Lovly, Christine M
Meiler, Jens
Arteaga, Carlos L

publication date

February 1, 2019

published in

Cancer discovery Journal

Identity

Scopus Document Identifier

85061247365

Digital Object Identifier (DOI)

10.1158/2159-8290.CD-18-1515

PubMed ID

30737217

Additional Document Info

volume

9

issue

2